Home » Paladin Labs Signs Agreement With QRxPharma for Acute Pain Product
Paladin Labs Signs Agreement With QRxPharma for Acute Pain Product
Paladin Labs entered into a licensing agreement with QRxPharma Limited, an Australian-based specialty pharmaceutical company, whereby Paladin received the exclusive rights to market and sell Moxduo (morphine and oxycodone) in Canada.
Equities
Equities
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May